1. Academic Validation
  2. In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR

In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR

  • Nat Metab. 2021 May;3(5):682-700. doi: 10.1038/s42255-021-00391-x.
Jérémie Charbord 1 Lipeng Ren  # 1 Rohit B Sharma  # 2 Anna Johansson 3 Rasmus Ågren 4 Lianhe Chu 1 Dominika Tworus 1 Nadja Schulz 1 Pierre Charbord 5 Andrew F Stewart 6 Peng Wang 6 Laura C Alonso 2 Olov Andersson 7
Affiliations

Affiliations

  • 1 Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • 2 Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY, USA.
  • 3 Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • 4 Department of Biology and Biological Engineering, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Chalmers University of Technology, Göteborg, Sweden.
  • 5 Sorbonne Université, Institut de Biologie Paris-Seine, CNRS UMR 7622, Inserm, Paris, France.
  • 6 Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • 7 Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. olov.andersson@ki.se.
  • # Contributed equally.
Abstract

It is known that β cell proliferation expands the β cell mass during development and under certain hyperglycemic conditions in the adult, a process that may be used for β cell regeneration in diabetes. Here, through a new high-throughput screen using a luminescence ubiquitination-based cell cycle indicator (LUCCI) in zebrafish, we identify HG-9-91-01 as a driver of proliferation and confirm this effect in mouse and human β cells. HG-9-91-01 is an inhibitor of salt-inducible kinases (SIKs), and overexpression of SIK1 specifically in β cells blocks the effect of HG-9-91-01 on β cell proliferation. Single-cell transcriptomic analyses of mouse β cells demonstrate that HG-9-91-01 induces a wave of activating transcription factor (ATF)6-dependent unfolded protein response (UPR) before cell cycle entry. Importantly, the UPR wave is not associated with an increase in Insulin expression. Additional mechanistic studies indicate that HG-9-91-01 induces multiple signalling effectors downstream of SIK inhibition, including CRTC1, CRTC2, ATF6, IRE1 and mTOR, which integrate to collectively drive β cell proliferation.

Figures
Products